Efficacy and Safety of Different Doses of Indacaterol in Chronic Obstructive Pulmonary Disease (COPD)

Completed · Phase 3 · Has a placebo group

Conditions studied: Chronic Obstructive Pulmonary Disease

In brief

This study compared the 14-day bronchodilator efficacy of indacaterol with that of placebo and salmeterol.

Key facts

Study ID

NCT01089127

Run by

Novartis Pharmaceuticals

People needed

552

Starts

2010-03-01

Expected to finish

2010-07-01

Last updated by the study team

2011-08-19

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of chronic obstructive pulmonary disease (COPD) (moderate-to-severe as classified by the Global Initiative for Chronic Obstructive Lung Disease [GOLD] Guidelines, 2008) and:
• Smoking history of at least 10 pack-years
• Post-bronchodilator forced expiratory volume in 1 second (FEV1) < 80% and ≥ 30% of the predicted normal value
• Post-bronchodilator FEV1/FVC (forced vital capacity) < 70%

You may not qualify if…

• Patients who have had a COPD exacerbation requiring systemic corticosteroids and/or antibiotics and/or hospitalization in the 6 weeks prior to screening
• Patients who have had a respiratory tract infection within 6 weeks prior to screening
• Patients with concomitant pulmonary disease
• Patients with a history of asthma
• Patients with diabetes Type I or uncontrolled diabetes Type II
• Any patient with lung cancer or a history of lung cancer
• Patients with a history of certain cardiovascular comorbid conditions
• Other protocol-defined inclusion/exclusion criteria applied to the study.

Where it is running

• Novartis Investigator Site — Jasper, Alabama, United States
• Novartis Investigator Site — Phoenix, Arizona, United States
• Novartis Investigator Site — Searcy, Arkansas, United States
• Novartis Investigator Site — Fullerton, California, United States
• Novartis Investigative Site — Rancho Mirage, California, United States
• Novartis Investigator Site — Riverside, California, United States
• Novartis Investigator Site — San Diego, California, United States
• Novartis Investigator Site — Stockton, California, United States
• Novartis Investigator Site — Temecula, California, United States
• Novartis Investigator Site — Walnut Creek, California, United States
• Novartis Investigator Site — Wheat Ridge, Colorado, United States
• Novartis Investigative Site — Glastonbury, Connecticut, United States
• Novartis Investigative Site — Stamford, Connecticut, United States
• Novartis Investigator Site — Clearwater, Florida, United States
• Novartis Investigator Site — DeFuniak Springs, Florida, United States
• Novartis Investigative Site — Hollywood, Florida, United States
• Novartis Investigator Site — Miami, Florida, United States
• Novartis Investigative Site — Pensacola, Florida, United States
• Novartis Investigative Site — Pensacola, Florida, United States
• Novartis Investigative Site — Tamarac, Florida, United States
• Novartis Investigator Site — Tampa, Florida, United States
• Novartis Investigator Site — O'Fallon, Illinois, United States
• Novartis Investigator Site — Florence, Kentucky, United States
• Novartis Investigator Site — Madisonville, Kentucky, United States
• Novartis Investigator Site — Florence, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.